Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11434022 | 0.93 | ESR1 (0.38) | ESR1ESR2 | |
| SCHEMBL29032529 | 0.91 | ESR1 (0.37) | ESR1ESR2 | |
| SCHEMBL30003065 | 0.91 | ESR1 (0.37) | ESR1ESR2 | |
| SCHEMBL94228 | 0.91 | ESR1 (0.39) | ESR1ESR2 | |
| SCHEMBL12977053 | 0.91 | LMNA (0.34) | ESR1ESR2 | |
| SCHEMBL16521498 | 0.89 | ESR1 (0.38) | ESR1ESR2 | |
| SCHEMBL8992173 | 0.89 | ESR1 (0.38) | ESR1ESR2 | |
| SCHEMBL18125 | 0.86 | ESR1 (0.39) | ESR1ESR2 | |
| SCHEMBL26973343 | 0.85 | ESR1 (0.33) | ESR1ESR2 | |
| SCHEMBL30002398 | 0.83 | ESR1 (0.32) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9789035-B2 | Lip composition in the form of an inverse emulsion comprising a humectant, and treatment process using the same | L'OREAL (FR) | 2017-10-17 | — | — | US | disclosed |
| US-9789035-B2 | Lip composition in the form of an inverse emulsion comprising a humectant, and treatment process using the same | L'OREAL (FR) | 2017-10-17 | — | — | US | disclosed |
| US-20170216183-A1 | EMULSION COMPRISING A SILICONE-BASED DENDRITIC FILM-FORMING POLYMER AND A SILICONE GUM, TREATMENT PROCESS USING THE SAME AND SUITABLE DEVICE | L'OREAL (FR) | 2017-08-03 | — | — | US | disclosed |
| US-20160310374-A1 | LIP COMPOSITION IN THE FORM OF AN INVERSE EMULSION COMPRISING A HUMECTANT, AND TREATMENT PROCESS USING THE SAME | L'OREAL (FR) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160310374-A1 | LIP COMPOSITION IN THE FORM OF AN INVERSE EMULSION COMPRISING A HUMECTANT, AND TREATMENT PROCESS USING THE SAME | LIPA, LIPE, LIPC | ESR1 2105/4885ESR2 2462/4885 |
| US-20170216183-A1 | EMULSION COMPRISING A SILICONE-BASED DENDRITIC FILM-FORMING POLYMER AND A SILICONE GUM, TREATMENT PROCESS USING THE SAME AND SUITABLE DEVICE | TLR9, TLR3, TLR7 | ESR1 3993/4885ESR2 4527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.